TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.94
+0.09 (0.12%)
At close: May 22, 2026, 4:00 PM EDT
68.46
-0.48 (-0.69%)
After-hours: May 22, 2026, 7:57 PM EDT
TransMedics Group Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $117.89. The average 1-year stock price forecast is 71.02% higher than the current stock price, while the lowest is $85 (+23.30%) and the highest is $142 (+105.99%).
Price Target: $117.89 (+71.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $152 → $124 | Strong Buy | Maintains | $152 → $124 | +79.88% | May 6, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $190 → $120 | Strong Buy | Maintains | $190 → $120 | +74.08% | May 6, 2026 |
| Stifel | Stifel | Hold Maintains $130 → $85 | Hold | Maintains | $130 → $85 | +23.30% | May 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $160 → $120 | Buy | Maintains | $160 → $120 | +74.08% | May 6, 2026 |
| Needham | Needham | Strong Buy Maintains $174 → $142 | Strong Buy | Maintains | $174 → $142 | +105.99% | May 6, 2026 |
Financial Forecast
Revenue This Year
747.96M
from 605.49M
Increased by 23.53%
Revenue Next Year
890.06M
from 747.96M
Increased by 19.00%
EPS This Year
2.17
from 4.87
Decreased by -55.54%
EPS Next Year
3.68
from 2.17
Increased by 69.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 779.2M | 952.0M | ||
| Avg | 748.0M | 890.1M | ||
| Low | 713.6M | 838.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 28.7% | 27.3% | ||
| Avg | 23.5% | 19.0% | ||
| Low | 17.9% | 12.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.53 | 4.97 | ||
| Avg | 2.17 | 3.68 | ||
| Low | 1.60 | 2.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -48.1% | 129.4% | ||
| Avg | -55.5% | 69.8% | ||
| Low | -67.2% | 29.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.